Showing 2,221 - 2,240 results of 2,271 for search '"Malawi"', query time: 0.11s Refine Results
  1. 2221
  2. 2222
  3. 2223

    Characterising paediatric mortality during and after acute illness in Sub-Saharan Africa and South Asia: a secondary analysis of the CHAIN cohort using a machine learning approachR... by Abdoulaye Hama Diallo, Abu Sadat Mohammad Sayeem Bin Shahid, Ali Fazal Khan, Ali Faisal Saleem, Benson O. Singa, Blaise Siezanga Gnoumou, Caroline Tigoi, Catherine Achieng Otieno, Celine Bourdon, Chris Odhiambo Oduol, Christina L. Lancioni, Christine Manyasi, Christine J. McGrath, Christopher Maronga, Christopher Lwanga, Daniella Brals, Dilruba Ahmed, Dinesh Mondal, Donna M. Denno, Dorothy I. Mangale, Emmanuel Chimezi, Emmie Mbale, Ezekiel Mupere, Gazi Md. Salahuddin Mamun, Issaka Ouedraogo, George Githinji, James A. Berkley, Jenala Njirammadzi, John Mukisa, Johnstone Thitiri, Jonas Haggstrom, Joseph D. Carreon, Judd L. Walson, Julie Jemutai, Kirkby D. Tickell, Lubaba Shahrin, MacPherson Mallewa, Md. Iqbal Hossain, Mohammod Jobayer Chisti, Molly Timbwa, Moses Mburu, Moses M. Ngari, Narshion Ngao, Peace Aber, Philliness Prisca Harawa, Priya Sukhtankar, Robert H.J. Bandsma, Roseline Maimouna Bamouni, Sassy Molyneux, Sergey Feldman, Shalton Mwaringa, Shamsun Nahar Shaima, Syed Asad Ali, Syeda Momena Afsana, Syera Banu, Tahmeed Ahmed, Wieger P. Voskuijl, Zaubina Kazi

    Published 2023-03-01
    “…Methods: A cohort of 3101 children aged 2–24 months were recruited at admission to hospital for any acute illness in Bangladesh (Dhaka and Matlab Hospitals), Pakistan (Civil Hospital Karachi), Kenya (Kilifi, Mbagathi, and Migori Hospitals), Uganda (Mulago Hospital), Malawi (Queen Elizabeth Central Hospital), and Burkina Faso (Banfora Hospital) from November 2016 to January 2019. …”
    Get full text
    Article
  4. 2224

    Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label,... by Mallewa, J, Szubert, A, Mugyenyi, P, Chidziva, E, Thomason, M, Chepkorir, P, Abongomera, G, Baleeta, K, Etyang, A, Warambwa, C, Melly, B, Mudzingwa, S, Kelly, C, Agutu, C, Wilkes, H, Nkomani, S, Musiime, V, Lugemwa, A, Pett, S, Bwakura-Dangarembizi, M, Prendergast, A, Gibb, D, Walker, A, Berkley, J, REALITY trial team

    Published 2018
    “…<strong>Methods</strong> We did a 2 × 2 × 2 factorial, open-label, parallel-group trial at inpatient and outpatient facilities in eight urban or periurban regional hospitals in Kenya, Malawi, Uganda, and Zimbabwe. Eligible participants were ART-naive adults and children aged at least 5 years with confirmed HIV infection and a CD4 cell count of fewer than 100 cells per μL, who were initiating ART at the facilities. …”
    Journal article
  5. 2225

    Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial by George, EC, Uyoga, S, M'baya, B, Kyeyune Byabazair, D, Kiguli, S, Olupot-Olupot, P, Opoka, R, Chagaluka, G, Alaroker, F, Williams, TN, Bates, I, Mbanya, D, Gibb, DM, Walker, AS, Maitland, K

    Published 2022
    “…TRACT was an open-label, multicentre, factorial, randomised trial conducted in three hospitals in Uganda (Soroti, Mbale, and Mulago) and one hospital in Malawi (Blantyre). The trial enrolled children aged between 2 months and 12 years admitted to hospital with severe anaemia (haemoglobin <6 g/dL). …”
    Journal article
  6. 2226
  7. 2227
  8. 2228
  9. 2229
  10. 2230
  11. 2231
  12. 2232
  13. 2233

    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. by Raphael J Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron

    Published 2018-11-01
    “…HIV Prevention Trials Network study 077 (HPTN 077) evaluated the safety, tolerability, and pharmacokinetics of CAB LA in HIV-uninfected males and females at 8 sites in Brazil, Malawi, South Africa, and the United States. METHODS AND FINDINGS:HPTN 077 was a double-blind, placebo-controlled phase 2a trial. …”
    Get full text
    Article
  14. 2234
  15. 2235
  16. 2236
  17. 2237

    Effects of women’s groups practising participatory learning and action on preventive and care-seeking behaviours to reduce neonatal mortality: A meta-analysis of cluster-randomised... by Seward, N, Neuman, M, Colbourn, T, Osrin, D, Lewycka, S, Azad, K, Costello, A, Das, S, Fottrell, E, Kuddus, A, Manandhar, D, Nair, N, Nambiar, B, Shah More, N, Phiri, T, Tripathy, P, Prost, A

    Published 2017
    “…</p><br/> <p><strong>Methods and Findings</strong><br/> We conducted a meta-analysis using data from 7 cluster-randomised controlled trials that took place between 2001 and 2012 in rural India (2 trials), urban India (1 trial), rural Bangladesh (2 trials), rural Nepal (1 trial), and rural Malawi (1 trial), with the number of participants ranging between 6,125 and 29,901 live births. …”
    Journal article
  18. 2238

    Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial by Kityo, C, Szubert, A, Siika, A, Heydermann, R, Bwakura-Dangarembizi, M, Lugemwa, A, Mwaringa, S, Griffiths, A, Nkanya, I, Kabahenda, S, Wachira, S, Musoro, G, Rajapakse, C, Etyang, T, Abach, J, Spyer, M, Wavamunno, P, Nyondo-Mipanda, L, Chidziva, E, Nathoo, K, Klein, N, Hakim, J, Gibb, D, Walker, A, Pett, S

    Published 2018
    “…<strong>Methods and findings:</strong> In a 2×2×2 factorial open-label parallel-group trial, treatment-naive adults, adolescents, and children &gt;5 years old infected with HIV, with cluster of differentiation 4 (CD4) &lt;100 cells/mm3, from eight urban/peri-urban HIV clinics at regional hospitals in Kenya, Malawi, Uganda, and Zimbabwe were randomised 1:1 to initiate standard triple-drug ART, with or without 12-week raltegravir intensification, and followed for 48 weeks. …”
    Journal article
  19. 2239

    Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estim... by Maria Deloria Knoll, Julia C. Bennett, Maria Garcia Quesada, Eunice W. Kagucia, Meagan E. Peterson, Daniel R. Feikin, Adam L. Cohen, Marissa K. Hetrich, Yangyupei Yang, Jenna N. Sinkevitch, Krow Ampofo, Laurie Aukes, Sabrina Bacci, Godfrey Bigogo, Maria-Cristina C. Brandileone, Michael G. Bruce, Romina Camilli, Jesús Castilla, Guanhao Chan, Grettel Chanto Chacón, Pilar Ciruela, Heather Cook, Mary Corcoran, Ron Dagan, Kostas Danis, Sara de Miguel, Philippe De Wals, Stefanie Desmet, Yvonne Galloway, Theano Georgakopoulou, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, James D. Kellner, Jackie Kleynhans, Mirjam J. Knol, Jana Kozakova, Karl Gústaf Kristinsson, Shamez N. Ladhani, Claudia S. Lara, Maria Eugenia León, Tiia Lepp, Grant A. Mackenzie, Lucia Mad’arová, Allison McGeer, Tuya Mungun, Jason M. Mwenda, J. Pekka Nuorti, Néhémie Nzoyikorera, Kazunori Oishi, Lucia Helena De Oliveira, Metka Paragi, Tamara Pilishvili, Rodrigo Puentes, Eric Rafai, Samir K. Saha, Larisa Savrasova, Camelia Savulescu, J. Anthony Scott, Kevin J. Scott, Fatima Serhan, Lena Petrova Setchanova, Nadja Sinkovec Zorko, Anna Skoczyńska, Todd D. Swarthout, Palle Valentiner-Branth, Mark van der Linden, Didrik F. Vestrheim, Anne von Gottberg, Inci Yildirim, Kyla Hayford, the PSERENADE Team

    Published 2021-04-01
    Get full text
    Article
  20. 2240